Wall Street brokerages expect that Cantel Medical Corp. (NYSE:CMD) will report $227.90 million in sales for the current quarter, Zacks reports. Two analysts have provided estimates for Cantel Medical’s earnings, with estimates ranging from $227.00 million to $228.80 million. Cantel Medical posted sales of $213.03 million in the same quarter last year, which suggests a positive year-over-year growth rate of 7%. The firm is expected to issue its next quarterly earnings report on Thursday, March 14th.
According to Zacks, analysts expect that Cantel Medical will report full year sales of $937.25 million for the current fiscal year, with estimates ranging from $931.80 million to $942.70 million. For the next fiscal year, analysts forecast that the business will report sales of $1.01 billion, with estimates ranging from $1.01 billion to $1.02 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side analysts that follow Cantel Medical.
Cantel Medical (NYSE:CMD) last posted its quarterly earnings results on Thursday, November 29th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.60 by $0.02. The firm had revenue of $225.59 million for the quarter, compared to the consensus estimate of $227.70 million. Cantel Medical had a net margin of 9.87% and a return on equity of 16.73%.
A number of research firms recently weighed in on CMD. Sidoti lowered their price target on Cantel Medical from $142.00 to $120.00 and set a “buy” rating on the stock in a report on Friday, September 28th. Raymond James cut their target price on shares of Cantel Medical from $115.00 to $108.00 and set an “outperform” rating on the stock in a report on Friday, September 28th. Finally, ValuEngine lowered shares of Cantel Medical from a “buy” rating to a “hold” rating in a report on Friday, September 28th.
Shares of CMD traded up $1.28 during midday trading on Wednesday, reaching $79.13. 208,028 shares of the stock were exchanged, compared to its average volume of 195,277. Cantel Medical has a 52 week low of $69.36 and a 52 week high of $130.92. The company has a market capitalization of $3.30 billion, a price-to-earnings ratio of 31.53 and a beta of 1.21. The company has a current ratio of 2.21, a quick ratio of 1.44 and a debt-to-equity ratio of 0.30.
The company also recently declared a Semi-Annual dividend, which will be paid on Thursday, January 31st. Stockholders of record on Thursday, January 17th will be paid a $0.10 dividend. The ex-dividend date of this dividend is Wednesday, January 16th. This is a positive change from Cantel Medical’s previous Semi-Annual dividend of $0.09. Cantel Medical’s payout ratio is currently 7.97%.
About Cantel Medical
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.
Further Reading: What is the LIBOR?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.